Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target

Oncogene, Published online: 23 December 2023; doi:10.1038/s41388-023-02925-xMyeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target

Source: Oncogene - December 23, 2023 Category: Cancer & Oncology Authors: Marina G. Ferrari Alexis P. Jimenez-Uribe Li Wang Luke H. Hoeppner Paari Murugan Eunsil Hahm Jindan Yu Timothy M. Kuzel Sergio A. Gradilone Adrian P. Mansini Source Type: research